Institute of Nursing and Health, College of Nursing and Health, Henan University, Kaifeng, Henan, China.
Arts Department, School of Kaifeng Culture and Tourism, Kaifeng, Henan, China.
Oxid Med Cell Longev. 2022 Oct 7;2022:9309327. doi: 10.1155/2022/9309327. eCollection 2022.
Tissue and organ ischemia can lead to cell trauma, tissue necrosis, irreversible damage, and death. While intended to reverse ischemia, reperfusion can further aggravate an ischemic injury (ischemia-reperfusion injury, I/R injury) through a range of pathologic processes. An I/R injury to one organ can also harm other organs, leading to systemic multiorgan failure. A type of carotenoid, lycopene, has been shown to treat and prevent many diseases (e.g., rheumatoid arthritis, cancer, diabetes, osteoporosis, male infertility, neurodegenerative diseases, and cardiovascular disease), making it a hot research topic in health care. Some recent researches have suggested that lycopene can evidently ameliorate ischemic and I/R injuries to many organs, but few clinical studies are available. Therefore, it is essential to review the effects of lycopene on ischemic and I/R injuries to different organs, which may help further research into its potential clinical applications.
组织和器官缺血可导致细胞损伤、组织坏死、不可逆损伤和死亡。虽然再灌注旨在逆转缺血,但通过一系列病理过程,再灌注可进一步加重缺血损伤(缺血再灌注损伤,I/R 损伤)。一个器官的 I/R 损伤也可能损害其他器官,导致全身多器官衰竭。一种类胡萝卜素,番茄红素,已被证明可以治疗和预防许多疾病(例如,类风湿性关节炎、癌症、糖尿病、骨质疏松症、男性不育、神经退行性疾病和心血管疾病),使其成为医疗保健领域的热门研究课题。一些最近的研究表明,番茄红素可以明显改善许多器官的缺血和 I/R 损伤,但临床研究很少。因此,有必要综述番茄红素对不同器官缺血再灌注损伤的作用,这可能有助于进一步研究其潜在的临床应用。